Leukotriene receptor antagonists
Drug Safety Update
April 2024: Montelukast: reminder of the risk of neuropsychiatric reactions
September 2019: Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions
NICE Guidance
NG80: Asthma diagnosis, monitoring and chronic asthma management, November 2017 (updated March 2021)
BTS/SIGN British Guideline on the management of asthma, July 2019
Local Guidance
See here for available local respiratory system guidance
Leukotriene receptor antagonists may be of benefit in exercise induced asthma and in those with concomitant rhinitis
Acute asthma: these agents should not be used to relieve an acute asthma attack and their use does not necessarily allow a reduction in existing corticosteroid treatment
| Pack | Price |
|---|---|
| 28 tablet | £1.31 |
| 30 tablet |
| Pack | Price |
|---|---|
| 28 tablet | £0.94 |
| 30 tablet |
| Pack | Price |
|---|---|
| 28 tablet | £1.11 |
| 30 tablet |